Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: Turkey (Türkiye) Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20141
20171
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
BeOne Medicines2
AbbVie1
Cellectar Biosciences, Inc.1
Incyte Corporation1
Janssen Research & Development, LLC1
MEI Pharma, Inc.1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Follicular11
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Mantle-Cell7
Lymphoma, Non-Hodgkin7
Waldenstrom Macroglobulinemia7
Multiple Myeloma5
Blast Crisis4
Burkitt Lymphoma4

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.